1. Home
  2. DNA vs ITIC Comparison

DNA vs ITIC Comparison

Compare DNA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.33

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Logo Investors Title Company

ITIC

Investors Title Company

HOLD

Current Price

$252.70

Market Cap

517.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNA
ITIC
Founded
2008
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
562.3M
517.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DNA
ITIC
Price
$8.33
$252.70
Analyst Decision
Strong Sell
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.0M
19.2K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
6.23%
EPS Growth
N/A
25.81
EPS
N/A
19.00
Revenue
$180,606,000.00
$273,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.28
N/A
P/E Ratio
N/A
$13.38
Revenue Growth
N/A
13.63
52 Week Low
$5.00
$190.20
52 Week High
$17.58
$288.98

Technical Indicators

Market Signals
Indicator
DNA
ITIC
Relative Strength Index (RSI) 35.56 44.08
Support Level $8.17 $248.74
Resistance Level $8.90 $260.66
Average True Range (ATR) 0.59 7.20
MACD -0.00 0.02
Stochastic Oscillator 1.01 51.48

Price Performance

Historical Comparison
DNA
ITIC

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About ITIC Investors Title Company

Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.

Share on Social Networks: